Speakers

Expand/Collapse

Lori Panther
Vice President, Clinical Development, Infectious Diseases
Moderna, Inc

Day One

Wednesday July 14 2021

11:00 am | Live Panel Q&A – Ask Speakers your Burning Questions

9:30 am | Messenger RNA (mRNA) Vaccine Against Cytomegalovirus (CMV) Infection: Phase 2 Interim Data

Jacob Becraft
Chief Scientific Officer & Co-Founder
Strand Therapeutics Inc

Day Two

Thursday July 15 2021

12:20 pm | Panel Discussion: On the Horizon: What is the Future of mRNA Treatments?

Daniel Griffith Anderson
Professor of Chemical Engineering
Institute for Medical Engineering and Science, Koch Institute for Integrative Cancer Research at MIT

Delivery & Manufacturing Focus Day

Tuesday July 13 2021

12:00 pm | Panel Discussion: Debating Between Techniques & Strategies for Optimized Delivery of mRNA Treatments

11:00 am | Live Panel Q&A – Ask Speakers your Burning Questions

9:00 am | Discussing Next Generation Delivery Techniques & Platforms for Highly Effective Delivery of mRNA

Laura Sepp-Lorenzino
Chief Scientific Officer
Intellia Therapeutics

Day Two

Thursday July 15 2021

3:30 pm | Live Panel Q&A – Ask Speakers your Burning Questions

2:30 pm | Transforming Medicine: In Vivo Therapeutic Genome Editing via Transient Expression of CRISPR/Cas9

Andreas Kuhn
Senior Vice President RNA Biochemistry & Manufacturing
BioNTech GmbH

Day One

Wednesday July 14 2021

11:00 am | Live Panel Q&A – Ask Speakers your Burning Questions

9:00 am | Learnings from the Speedy Development of an mRNA-Based COVID-19 Vaccine

Russell Johnson
Local Head Basic Pharmaceutical Sciences
Drug Product, GSK Vaccines

Day One

Wednesday July 14 2021

10:00 am | Pharmacology of Optimal mRNA Therapies for Infectious Disease Considering Safety, Efficacy & Translatability

11:00 am | Live Panel Q&A – Ask Speakers your Burning Questions

Allison August
Vice President, Clinical Development, Infectious Diseases
Moderna, Inc

Day Two

Thursday July 15 2021

11:50 am | Results of A Phase 1 Trial Demonstrating mRNA Can Encode & Produce Potentially Therapeutic Levels of a Monoclonal Antibody with Neutralizing Activity Against Chikungunya Virus

Norman Begg
Independent Vaccine Consultant, Former Chief Medical Officer
GSK Vaccines

Day Two

Thursday July 15 2021

12:20 pm | Panel Discussion: On the Horizon: What is the Future of mRNA Treatments?

Venkata R Krishnamurthy
Director & Senior Advisor
Eli Lilly & Company 

Day One

Wednesday July 14 2021

6:00 pm | Chair’s Closing Remarks

5:45 pm | Live Panel Q&A – Ask Speakers your Burning Questions

3:45 pm | Live Panel Q&A - Ask Speakers your Burning Questions!

1:40 pm | Live Panel Q&A – Ask Speakers your Burning Questions

11:00 am | Live Panel Q&A – Ask Speakers your Burning Questions

8:50 am | Chair’s Opening Remarks

Delivery & Manufacturing Focus Day

Tuesday July 13 2021

12:00 pm | Panel Discussion: Debating Between Techniques & Strategies for Optimized Delivery of mRNA Treatments

Tasuku Kitada
Co-Founder, Director, President, & Head of R&D
Strand Therapeutics

Day One

Wednesday July 14 2021

3:45 pm | Live Panel Q&A - Ask Speakers your Burning Questions!

2:45 pm | Overview of Current Successes & Landscape of Clinical Data for mRNA Oncology Treatments

Lusong Luo
Senior Vice President, External Innovation
BeiGene

Day Two

Thursday July 15 2021

12:20 pm | Panel Discussion: On the Horizon: What is the Future of mRNA Treatments?

Carsten Rudolph
Managing Director & Chief Scientific Officer
Ethris GmbH

Day Two

Thursday July 15 2021

10:30 am | Live Panel Q&A - Ask Speakers your Burning Questions

9:30 am | Immuno-Modulation & mRNA-based Protein Replacement Therapy Programs for Treatment of Pulmonary Disease

Lior Zangi
Associate Professor
Icahn School of Medicine at Mount Sinai

Day Two

Thursday July 15 2021

10:30 am | Live Panel Q&A - Ask Speakers your Burning Questions

9:00 am | mRNA-Based Approach for Treating Ischemic Heart Disease

Joseph Barberio
Director, mRNA Process Development
Strand Therapeutics Inc

Delivery & Manufacturing Focus Day

Tuesday July 13 2021

3:15 pm | Panel Discussion: Delving into Optimized the Process Development to Support mRNA Therapeutic Development & Assess Clinical Translation Efficiency

Kristy Wood
Senior Director, Technical Operations
Intellia Therapeutics

Delivery & Manufacturing Focus Day

Tuesday July 13 2021

3:15 pm | Panel Discussion: Delving into Optimized the Process Development to Support mRNA Therapeutic Development & Assess Clinical Translation Efficiency

2:15 pm | A Platform Manufacturing Approach to CRISPR/Cas9 Genome Editing Therapeutics

Jay Sarkar
Co-founder & Chief Technology Officer
Turn Biotechnologies

Day Two

Thursday July 15 2021

10:30 am | Live Panel Q&A - Ask Speakers your Burning Questions

10:00 am | mRNA Applications in Epigenetic Therapy

Mouhannad Jumaa
Senior Vice President of Pharmaceutical Development
Turn Biotechnologies

Delivery & Manufacturing Focus Day

Tuesday July 13 2021

12:00 pm | Panel Discussion: Debating Between Techniques & Strategies for Optimized Delivery of mRNA Treatments

Anthony Partridge
Senior Principal Scientist
MSD Singapore

Day One

Wednesday July 14 2021

5:45 pm | Live Panel Q&A – Ask Speakers your Burning Questions

4:45 pm | Exquisitely Specific Anti-KRAS Biodegraders – Informing Cellular Prevalence of Nucleotide-Loaded States

Ali Miserez
Professor
Nanyang Technological University, Singapore

Delivery & Manufacturing Focus Day

Tuesday July 13 2021

11:00 am | Live Panel Q&A – Ask Speakers your Burning Questions

9:30 am | Biomimetic Peptide Coacervates as Safe & Efficient Delivery Vehicles of Macromolecular Therapeutics

Shu-Bing Qian
Professor
Cornell University

Day One

Wednesday July 14 2021

3:45 pm | Live Panel Q&A - Ask Speakers your Burning Questions!

3:15 pm | Targeting Cancer Using Artificial mRNA Treatments

Vittorio Sebastiano
Assistant Professor OBGyN
Stanford University

Day Two

Thursday July 15 2021

3:30 pm | Live Panel Q&A – Ask Speakers your Burning Questions

3:00 pm | Reversing the Irreversible: Epigenetic Reprogramming of Aging Through mRNAs

Gal Cafri
Immunotherapy & Genetic Engineering Group Leader
Sheba Medical Center

Day One

Wednesday July 14 2021

5:45 pm | Live Panel Q&A – Ask Speakers your Burning Questions

5:15 pm | Insights from the Development of a Personalized mRNA Vaccine for Gastrointestinal Cancer Patients

Day Two

Thursday July 15 2021

12:20 pm | Panel Discussion: On the Horizon: What is the Future of mRNA Treatments?

Pad Chivukula
Chief Scientific Officer & Chief Operating Officer
Arcturus Therapeutics

Day One

Wednesday July 14 2021

1:40 pm | Live Panel Q&A – Ask Speakers your Burning Questions

12:30 pm | LUNAR®-COV19: The Arcturus Therapeutics SARS-CoV-2 mRNA Vaccine Candidate

Yizhou Dong
Associate Professor
The Ohio State University 

Delivery & Manufacturing Focus Day

Tuesday July 13 2021

11:00 am | Live Panel Q&A – Ask Speakers your Burning Questions

10:00 am | Novel Delivery Appriaches to Enhance Stability, Effectivity & Safety of mRNA Therapies

Nicolas Havelange
CMC Lead
CEPI

Delivery & Manufacturing Focus Day

Tuesday July 13 2021

3:15 pm | Panel Discussion: Delving into Optimized the Process Development to Support mRNA Therapeutic Development & Assess Clinical Translation Efficiency

1:45 pm | Deliberating Novel Delivery & Advanced Manufacturing of mRNA Therapies to Optimize Commercialization

Pooja Tiwari
Associate Scientist
Emory School of Medicine  

Day One

Wednesday July 14 2021

1:40 pm | Live Panel Q&A – Ask Speakers your Burning Questions

1:00 pm | mRNA Therapeutics for Infectious Diseases: The CRISPR-Cas13 Way

Jimmy Chu
Scientist II, mRNA Process Development
bluebird bio

Delivery & Manufacturing Focus Day

Tuesday July 13 2021

3:15 pm | Panel Discussion: Delving into Optimized the Process Development to Support mRNA Therapeutic Development & Assess Clinical Translation Efficiency

2:45 pm | Process Development – From Design & Development to Technology Transfer of mRNA Drug Substance Manufacturing Process

James Sullivan
Senior Vice President Pulmonary Research
Translate Bio

Day Two

Thursday July 15 2021

2:00 pm | Advancing Delivery Of mRNA Therapeutics For The Treatment Of Genetic Diseases

Dushyant Varshney
Executive Vice President & Chief Technology Officer
Arcturus Therapeutics

Delivery & Manufacturing Focus Day

Tuesday July 13 2021

10:30 am | Commercialization and Technology Transfer of mRNA Therapeutics and Lyophilized Vaccines

11:00 am | Live Panel Q&A – Ask Speakers your Burning Questions

Aalok Shah
Associate Director, Formulation Design
Strand Therapeutics Inc.

Delivery & Manufacturing Focus Day

Tuesday July 13 2021

12:00 pm | Panel Discussion: Debating Between Techniques & Strategies for Optimized Delivery of mRNA Treatments

BIA Separations

Day One

Wednesday July 14 2021

10:30 am | Session Reserved for BIA Separations

Uwe Gottschalk
Chief Scientific Officer
Lonza

Delivery & Manufacturing Focus Day

Tuesday July 13 2021

12:00 pm | Panel Discussion: Debating Between Techniques & Strategies for Optimized Delivery of mRNA Treatments

Michael Buschmann
Co-founder & Chief Scientific Officer
AexeRNA Therapeutics

Day One

Wednesday July 14 2021

1:30 pm | The AexLNPTM System: Next Generation Lipid Nanoparticles Unlocking mRNA Therapeutic Opportunities